Unknown

Dataset Information

0

Plant-Produced Nanoparticles Based on Artificial Self-Assembling Peptide Bearing the Influenza M2e Epitope.


ABSTRACT: Despite advances in vaccine development, influenza remains a persistent global health threat and the search for a broad-spectrum recombinant vaccine against influenza continues. The extracellular domain of the transmembrane protein M2 (M2e) of the influenza A virus is highly conserved and can be used to develop a universal vaccine. M2e is a poor immunogen by itself, but it becomes highly immunogenic when linked to an appropriate carrier. Here, we report the transient expression of a recombinant protein comprising four tandem copies of M2e fused to an artificial self-assembling peptide (SAP) in plants. The hybrid protein was efficiently expressed in Nicotiana benthamiana using the self-replicating potato virus X-based vector pEff. The protein was purified using metal affinity chromatography under denaturing conditions. The hybrid protein was capable of self-assembly in vitro into spherical particles 15-30 nm in size. The subcutaneous immunization of mice with M2e-carrying nanoparticles induced high levels of M2e-specific IgG antibodies in serum and mucosal secretions. Immunization provided mice with protection against a lethal influenza A virus challenge. SAP-based nanoparticles displaying M2e peptides can be further used to develop a recombinant "universal" vaccine against influenza A produced in plants.

SUBMITTER: Blokhina EA 

PROVIDER: S-EPMC10255905 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Plant-Produced Nanoparticles Based on Artificial Self-Assembling Peptide Bearing the Influenza M2e Epitope.

Blokhina Elena A EA   Mardanova Eugenia S ES   Zykova Anna A AA   Stepanova Liudmila A LA   Shuklina Marina A MA   Tsybalova Liudmila M LM   Ravin Nikolai V NV  

Plants (Basel, Switzerland) 20230605 11


Despite advances in vaccine development, influenza remains a persistent global health threat and the search for a broad-spectrum recombinant vaccine against influenza continues. The extracellular domain of the transmembrane protein M2 (M2e) of the influenza A virus is highly conserved and can be used to develop a universal vaccine. M2e is a poor immunogen by itself, but it becomes highly immunogenic when linked to an appropriate carrier. Here, we report the transient expression of a recombinant  ...[more]

Similar Datasets

| S-EPMC3248878 | biostudies-literature
| S-EPMC5572660 | biostudies-literature
| S-EPMC4928777 | biostudies-literature
| S-EPMC4418433 | biostudies-literature
| S-EPMC5816751 | biostudies-literature
| S-EPMC7457018 | biostudies-literature
| S-EPMC9779006 | biostudies-literature
| S-EPMC7294693 | biostudies-literature
| S-EPMC7020208 | biostudies-literature
| S-EPMC5066668 | biostudies-literature